Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew B Lassman

Showing results (51-60 of 145) with videos related to

Pageof 15
Sort By:
Journal of Neuro-Oncology|December 14, 2005
Systemic high-dose intravenous methotrexate for central nervous system metastasesAndrew B Lassman, Lauren E Abrey, Gaurav D Shah, et al.
Journal of Neuro-Oncology|November 20, 2008
A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM)Teri N Kreisl, Andrew B Lassman, Paul S Mischel, et al.
Journal of Neuro-Oncology|April 30, 2015
Radiotherapy and temozolomide for anaplastic astrocytic gliomasLakshmi Nayak, Katherine S Panageas, Anne S Reiner, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2012
Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade gliomaLauren Q Shapiro, Kathryn Beal, Anuj Goenka, et al.
Journal of Neuro-Oncology|July 21, 2019
Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastomaThomas J Kaley, Katherine S Panageas, Ingo K Mellinghoff, et al.
Journal of Neuro-Oncology|August 7, 2014
Fetal radiation monitoring and dose minimization during intensity modulated radiation therapy for glioblastoma in pregnancyDavid P Horowitz, Tony J C Wang, Cheng-Shie Wuu, et al.
Neuro-Oncology|April 17, 2007
Survey of treatment recommendations for anaplastic oligodendrogliomaLauren E Abrey, David N Louis, Nina Paleologos, et al.
Journal of Neuro-Oncology|July 9, 2011
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment deliveryMark R Gilbert, John Kuhn, Kathleen R Lamborn, et al.
Journal of Neuro-Oncology|May 5, 2010
Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancerKevin C De Braganca, Yelena Y Janjigian, Christopher G Azzoli, et al.
Seminars in Radiation Oncology|June 7, 2020
Repeat Radiation in the Brain: Managing Patients With Locally Recurrent GliomaDaniel M Trifiletti, Timothy D Malouff, Susan L McGovern, et al.
Pageof 15

Showing results (51-60 of 145) with videos related to

Sort By:
Pageof 15
Journal of Neuro-Oncology|December 14, 2005
Systemic high-dose intravenous methotrexate for central nervous system metastasesAndrew B Lassman, Lauren E Abrey, Gaurav D Shah, et al.
Journal of Neuro-Oncology|November 20, 2008
A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM)Teri N Kreisl, Andrew B Lassman, Paul S Mischel, et al.
Journal of Neuro-Oncology|April 30, 2015
Radiotherapy and temozolomide for anaplastic astrocytic gliomasLakshmi Nayak, Katherine S Panageas, Anne S Reiner, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2012
Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade gliomaLauren Q Shapiro, Kathryn Beal, Anuj Goenka, et al.
Journal of Neuro-Oncology|July 21, 2019
Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastomaThomas J Kaley, Katherine S Panageas, Ingo K Mellinghoff, et al.
Journal of Neuro-Oncology|August 7, 2014
Fetal radiation monitoring and dose minimization during intensity modulated radiation therapy for glioblastoma in pregnancyDavid P Horowitz, Tony J C Wang, Cheng-Shie Wuu, et al.
Neuro-Oncology|April 17, 2007
Survey of treatment recommendations for anaplastic oligodendrogliomaLauren E Abrey, David N Louis, Nina Paleologos, et al.
Journal of Neuro-Oncology|July 9, 2011
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment deliveryMark R Gilbert, John Kuhn, Kathleen R Lamborn, et al.
Journal of Neuro-Oncology|May 5, 2010
Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancerKevin C De Braganca, Yelena Y Janjigian, Christopher G Azzoli, et al.
Seminars in Radiation Oncology|June 7, 2020
Repeat Radiation in the Brain: Managing Patients With Locally Recurrent GliomaDaniel M Trifiletti, Timothy D Malouff, Susan L McGovern, et al.
Pageof 15